Evelo Biosciences, Inc.
US ˙ OTCPK ˙ US2997342025

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for David R Epstein. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at David R Epstein har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
Director 27.041
US:SGEN / Seagen Inc CEO, Director 0
US:EVLO / Evelo Biosciences, Inc. Director 93.932
US:SNTI / Senti Biosciences, Inc. Director 123.252
US:AXLA / Axcella Health Inc. Director 209.756
US:RUBY / Rubius Therapeutics, Inc. Director 499.762
US:US6710051060 / OPY Acquisition Corp. I Director 0
US:IFF / International Flavors & Fragrances Inc. Director 6.397
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af David R Epstein. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb EVLO / Evelo Biosciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i EVLO / Evelo Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-05-27 EVLO Epstein David R 17.123 1,4600 856 29,2000 25.000 73 60.2 26.532 106,13
2020-12-11 EVLO Epstein David R 200 6,4000 10 128,0000 1.280
2020-12-11 EVLO Epstein David R 30 6,4500 2 129,0000 194
2020-12-11 EVLO Epstein David R 4.970 6,4900 248 129,8000 32.255
2020-12-11 EVLO Epstein David R 800 7,1600 40 143,2000 5.728
2020-12-11 EVLO Epstein David R 1.000 6,9100 50 138,2000 6.910
2020-12-11 EVLO Epstein David R 500 6,9800 25 139,6000 3.490
2020-12-11 EVLO Epstein David R 200 7,0200 10 140,4000 1.404
2020-08-31 EVLO Epstein David R 2.752 4,4600 138 89,2000 12.274
2020-08-31 EVLO Epstein David R 1.000 4,4700 50 89,4000 4.470
2020-08-31 EVLO Epstein David R 1.000 4,4800 50 89,6000 4.480
2020-08-31 EVLO Epstein David R 1.000 4,5800 50 91,6000 4.580
2020-08-28 EVLO Epstein David R 1.000 4,3400 50 86,8000 4.340
2020-08-28 EVLO Epstein David R 3.248 4,4000 162 88,0000 14.291

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EVLO / Evelo Biosciences, Inc. Insider Trades
Insidersalg EVLO / Evelo Biosciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i EVLO / Evelo Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EVLO / Evelo Biosciences, Inc. Insider Trades
Insiderkøb SNTI / Senti Biosciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i EVLO / Evelo Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SNTI / Senti Biosciences, Inc. Insider Trades
Insidersalg SNTI / Senti Biosciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i EVLO / Evelo Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SNTI / Senti Biosciences, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af David R Epstein som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-09-04 2025-09-02 4 TEM Tempus AI, Inc.
Class A Comnmon Stock
S - Sale X -250 27.041 -0,92 73,64 -18.410 1.991.299
2025-08-05 2025-08-01 4 TEM Tempus AI, Inc.
Class A Comnmon Stock
S - Sale X -370 27.291 -1,34 55,16 -20.409 1.505.372
2025-06-04 2025-06-02 4 TEM Tempus AI, Inc.
Class A Comnmon Stock
S - Sale X -250 27.661 -0,90 55,20 -13.800 1.526.887
2025-05-22 2025-05-20 4 TEM Tempus AI, Inc.
Class A Comnmon Stock
A - Award 1.997 27.911 7,71
2025-05-05 2025-05-01 4 TEM Tempus AI, Inc.
Class A Common Stock
S - Sale X -370 25.914 -1,41 53,50 -19.795 1.386.399
2025-03-19 2025-03-17 4 TEM Tempus AI, Inc.
Class A Common Stock
S - Sale X -990 26.284 -3,63 46,83 -46.362 1.230.880
2025-03-05 2025-03-03 4 TEM Tempus AI, Inc.
Class A Common Stock
S - Sale X -250 27.274 -0,91 57,52 -14.380 1.568.800
2025-02-05 2025-02-03 4 TEM Tempus AI, Inc.
Class A Common Stock
S - Sale X -370 27.524 -1,33 53,31 -19.725 1.467.304
2024-12-13 2024-12-11 4 TEM Tempus AI, Inc.
Class A Common Stock
S - Sale X -620 27.894 -2,17 41,81 -25.922 1.166.248
2024-06-17 2024-06-13 4 TEM Tempus AI, Inc.
Class A Common Stock
A - Award 28.514 28.514
2023-12-15 2023-12-14 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer -16.407 0 -100,00 229,00 -3.757.203
2023-11-13 2023-11-10 4 SGEN Seagen Inc.
Common Stock
S - Sale X -10.620 136.598 -7,21 213,01 -2.262.166 29.096.740
2023-08-17 2023-08-15 4 SGEN Seagen Inc.
Common Stock
A - Award 39.650 147.218 36,86
2022-11-14 2022-11-09 4 SGEN Seagen Inc.
Common Stock
A - Award 107.389 107.389
2022-06-30 2022-06-30 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.874 93.932 3,16
2022-06-30 2022-06-30 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.053 91.058 2,31
2022-06-10 2022-06-08 4 SNTI Dynamics Special Purpose Corp.
Common Stock
A - Award 112.519 123.252 1.048,35
2022-06-03 2022-05-19 4 AXLA Axcella Health Inc.
Common Stock
A - Award 47.059 209.756 28,92
2022-06-01 2022-05-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.873 89.005 3,34
2022-06-01 2022-05-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.052 86.132 2,44
2022-05-31 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 17.123 84.080 25,57 1,46 25.000 122.757
2022-05-13 2022-05-12 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 499.762 499.762
2022-05-02 2022-05-02 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.873 5.747 -33,33
2022-05-02 2022-05-02 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.053 4.105 -33,34
2022-05-02 2022-05-02 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.873 66.957 4,48
2022-05-02 2022-05-02 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.053 64.084 3,31
2022-04-22 2022-04-21 4 RUBY Rubius Therapeutics, Inc.
Common Stock
P - Purchase 30.000 4.720.012 0,64 1,44 43.329 6.817.113
2022-04-01 2022-03-31 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.874 8.620 -25,00
2022-04-01 2022-03-31 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.052 6.158 -24,99
2022-04-01 2022-03-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.874 62.031 4,86
2022-04-01 2022-03-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.052 59.157 3,59
2022-03-21 2022-03-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.535 0 -100,00
2022-03-21 2022-03-18 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.535 162.697 0,95
2022-03-21 2022-03-17 4 AXLA Axcella Health Inc.
Stock Option (Right to Buy)
A - Award 50.000 50.000
2022-03-18 2022-03-16 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 26.178 161.162 19,39 1,91 50.000 307.819
2022-03-01 2022-02-28 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.873 11.494 -20,00
2022-03-01 2022-02-28 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.053 8.210 -20,00
2022-03-01 2022-02-28 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.873 57.105 5,30
2022-03-01 2022-02-28 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.053 54.232 3,93
2022-02-23 2022-02-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.534 1.535 -49,98
2022-02-23 2022-02-18 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.534 134.984 1,15
2022-01-31 2022-01-31 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.873 14.367 -16,66
2022-01-31 2022-01-31 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.052 10.263 -16,66
2022-01-31 2022-01-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.873 52.179 5,83
2022-01-31 2022-01-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.052 49.306 4,34
2022-01-20 2022-01-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.535 3.069 -33,34
2022-01-20 2022-01-18 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.535 133.450 1,16
2022-01-03 2021-12-31 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.874 17.240 -14,29
2022-01-03 2021-12-31 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.052 12.315 -14,28
2022-01-03 2021-12-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.874 47.254 6,48
2022-01-03 2021-12-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.052 44.380 4,85
2021-12-20 2021-12-17 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.535 4.604 -25,00
2021-12-20 2021-12-17 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.535 131.915 1,18
2021-12-01 2021-11-30 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.873 20.114 -12,50
2021-12-01 2021-11-30 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.053 14.367 -12,50
2021-12-01 2021-11-30 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.873 42.328 7,28
2021-12-01 2021-11-30 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.053 39.455 5,49
2021-11-22 2021-11-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.534 6.139 -19,99
2021-11-22 2021-11-18 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.534 130.380 1,19
2021-11-01 2021-11-01 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.873 22.987 -11,11
2021-11-01 2021-11-01 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.052 16.420 -11,11
2021-11-01 2021-11-01 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.873 37.402 8,32
2021-11-01 2021-11-01 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.052 34.529 6,32
2021-10-26 3 OHAA Opy Acquisition Corp. I
Common Stock
0
2021-10-19 2021-10-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.535 7.673 -16,67
2021-10-19 2021-10-18 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.535 128.846 1,21
2021-10-01 2021-10-01 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.874 25.860 -10,00
2021-10-01 2021-10-01 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -2.053 18.472 -10,00
2021-10-01 2021-10-01 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.874 32.477 9,71
2021-10-01 2021-10-01 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 2.053 29.603 7,45
2021-09-20 2021-09-17 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.535 9.208 -14,29
2021-09-20 2021-09-17 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.535 127.311 1,22
2021-09-03 2021-09-03 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -5.746 28.734 -16,66
2021-09-03 2021-09-03 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
M - Exercise -4.104 20.525 -16,66
2021-09-03 2021-09-03 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 5.746 27.550 26,35
2021-09-03 2021-09-03 4 EVLO Evelo Biosciences, Inc.
Common Stock
M - Exercise 4.104 21.804 23,19
2021-08-19 2021-08-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.534 10.743 -12,49
2021-08-19 2021-08-18 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.534 125.776 1,23
2021-07-20 2021-07-16 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.535 12.277 -11,11
2021-07-20 2021-07-16 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.535 124.242 1,25
2021-07-02 2021-06-30 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
A - Award 34.480 34.480
2021-07-02 2021-06-30 4 EVLO Evelo Biosciences, Inc.
Restricted Stock Units
A - Award 24.629 24.629
2021-06-21 2021-06-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.535 13.812 -10,00
2021-06-21 2021-06-18 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.535 122.707 1,27
2021-05-25 3 DYNS Dynamics Special Purpose Corp.
Class A common stock
10.733
2021-05-20 2021-05-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.534 15.347 -9,09
2021-05-20 2021-05-18 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.534 121.172 1,28
2021-05-13 2021-05-12 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 27.919 27.919
2021-04-20 2021-04-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
M - Exercise -1.535 16.881 -8,34
2021-04-20 2021-04-18 4 AXLA Axcella Health Inc.
Common Stock
M - Exercise 1.535 119.638 1,30
2021-03-22 2021-03-18 4 AXLA Axcella Health Inc.
Stock Option (Right to Buy)
A - Award 120.000 120.000
2021-03-22 2021-03-18 4 AXLA Axcella Health Inc.
Restricted Stock Units
A - Award 18.416 18.416
2021-02-16 2021-02-11 4 RUBY Rubius Therapeutics, Inc.
Common Stock
S - Sale X -26.704 4.690.012 -0,57 14,93 -398.560 69.998.898
2021-02-10 2021-02-10 4 RUBY Rubius Therapeutics, Inc.
Common Stock
S - Sale X -7.404 4.716.716 -0,16 14,79 -109.525 69.772.965
2021-02-10 2021-02-09 4 RUBY Rubius Therapeutics, Inc.
Common Stock
S - Sale X -2.100 4.724.120 -0,04 14,83 -31.146 70.065.313
2021-02-10 2021-02-08 4 RUBY Rubius Therapeutics, Inc.
Common Stock
S - Sale X -89.233 4.726.220 -1,85 14,88 -1.328.117 70.343.641
2020-12-14 2020-12-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 200 17.700 1,14 7,02 1.404 124.254
2020-12-14 2020-12-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 500 17.500 2,94 6,98 3.490 122.150
2020-12-14 2020-12-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1.000 17.000 6,25 6,91 6.910 117.470
2020-12-14 2020-12-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 800 16.000 5,26 7,16 5.728 114.560
2020-12-14 2020-12-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 4.970 15.200 48,58 6,49 32.255 98.648
2020-12-14 2020-12-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 30 10.230 0,29 6,45 194 65.984
2020-12-14 2020-12-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 200 10.200 2,00 6,40 1.280 65.280
2020-11-04 2020-11-02 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 1.071 6.397 20,10 105,07 112.500 672.182
2020-10-14 2020-10-11 4 EVLO Evelo Biosciences, Inc.
Stock Option (Right to Buy)
A - Award 44.743 44.743
2020-10-14 2020-10-11 4 EVLO Evelo Biosciences, Inc.
Stock Option (Right to Buy)
A - Award 59.395 59.395
2020-09-01 2020-08-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1.000 10.000 11,11 4,58 4.580 45.800
2020-09-01 2020-08-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1.000 9.000 12,50 4,48 4.480 40.320
2020-09-01 2020-08-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1.000 8.000 14,29 4,47 4.470 35.760
2020-09-01 2020-08-31 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 2.752 7.000 64,78 4,46 12.274 31.220
2020-09-01 2020-08-28 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 3.248 4.248 324,80 4,40 14.291 18.691
2020-09-01 2020-08-28 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1.000 1.000 4,34 4.340 4.340
2020-06-08 2020-06-05 4 AXLA Axcella Health Inc.
Stock Option (Right to Buy)
A - Award 6.800 6.800
2020-05-26 2020-05-21 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 115.771 115.771
2020-05-22 2020-05-20 4 AXLA Axcella Health Inc.
Stock Option (Right to Buy)
A - Award 65.000 65.000
2020-05-22 2020-05-20 4 AXLA Axcella Health Inc.
Stock Option (Right to Buy)
A - Award 35.000 35.000
2020-05-20 2020-05-18 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 50.000 118.103 73,42 4,75 237.500 560.989
2020-05-08 2020-05-06 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 1 5.255 0,02 131,31 107 690.096
2020-05-08 2020-05-06 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
A - Award 1.047 1.047
2020-05-05 2020-05-01 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 997 5.255 23,42
2020-05-05 2020-05-01 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
D - Sale to Issuer -997 0 -100,00
2020-03-19 2020-03-17 4 RUBY Rubius Therapeutics, Inc.
Common Stock
P - Purchase 5.000 4.815.453 0,10 3,76 18.800 18.106.103
2020-03-17 2020-03-13 4 RUBY Rubius Therapeutics, Inc.
Common Stock
P - Purchase 5.000 4.810.453 0,10 4,00 20.000 19.241.812
2020-03-17 2020-03-13 4 RUBY Rubius Therapeutics, Inc.
Common Stock
P - Purchase 5.000 4.805.453 0,10 3,82 19.100 18.356.830
2020-03-02 2020-02-28 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 2.005 68.103 3,03 3,75 7.519 255.386
2020-03-02 2020-02-27 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 12.800 66.098 24,02 3,65 46.720 241.258
2019-12-03 2019-11-27 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 1.005 53.298 1,92 3,91 3.930 208.395
2019-12-03 2019-11-26 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 14.000 52.293 36,56 3,55 49.700 185.640
2019-12-02 2019-11-27 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 1.005 53.298 1,92 3,91 3.930 208.395
2019-12-02 2019-11-26 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 14.000 52.293 36,56 3,55 49.700 185.640
2019-11-05 2019-11-01 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 462 4.203 12,35 121,74 56.250 511.721
2019-09-17 2019-09-14 4 EVLO Evelo Biosciences, Inc.
Stock Option (Right to Buy)
A - Award 75.000 75.000
2019-09-17 2019-09-14 4 EVLO Evelo Biosciences, Inc.
Stock Option (Right to Buy)
A - Award 75.000 75.000
2019-08-23 2019-08-21 4 AXLA Axcella Health Inc.
Stock Option (Right to Buy)
A - Award 65.000 65.000
2019-08-23 2019-08-21 4 AXLA Axcella Health Inc.
Stock Option (Right to Buy)
A - Award 35.000 35.000
2019-08-05 2019-08-02 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 2.849 38.293 8,04 7,04 20.057 269.583
2019-08-05 2019-08-01 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 4.092 35.444 13,05 6,98 28.562 247.399
2019-07-18 2019-07-17 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 1.000 31.352 3,29 7,55 7.550 236.708
2019-07-10 2019-07-10 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 1.322 30.352 4,55 8,07 10.669 244.941
2019-07-10 2019-07-09 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 4.200 29.030 16,92 8,24 34.608 239.207
2019-07-10 2019-07-08 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 274 24.830 1,12 9,00 2.466 223.470
2019-07-03 2019-07-03 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 56 19.056 0,29 8,99 503 171.313
2019-07-03 2019-07-02 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 3.500 19.000 22,58 8,76 30.678 166.535
2019-07-03 2019-07-01 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 1.000 15.500 6,90 8,74 8.735 135.392
2019-07-01 2019-06-28 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 5.400 20.000 36,99 10,04 54.216 200.800
2019-07-01 2019-06-27 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 100 14.600 0,69 9,15 915 133.590
2019-06-27 2019-06-26 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 14.500 14.500 9,57 138.765 138.765
2019-06-13 2019-06-12 4 EVLO Evelo Biosciences, Inc.
Stock Option (Right to Buy)
A - Award 15.690 15.690
2019-05-28 2019-05-23 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 39.094 39.094
2019-05-24 2019-05-22 4 AXLA Axcella Health Inc.
Stock Option (Right to Buy)
A - Award 11.000 11.000
2019-05-03 2019-05-02 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 874 3.699 30,93
2019-05-03 2019-05-02 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
D - Sale to Issuer -874 0 -100,00
2019-05-03 2019-05-01 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
A - Award 997 997
2019-02-14 2018-11-28 5 RUBY Rubius Therapeutics, Inc.
Common Stock
G - Gift 180.000 180.000
2019-02-14 2018-11-28 5 RUBY Rubius Therapeutics, Inc.
Common Stock
G - Gift -180.000 4.800.453 -3,61
2019-02-14 2018-12-31 5 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 48 2.795 1,75
2018-07-18 2018-07-17 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 1.902.977 1.902.977
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
9.960.906
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
9.960.906
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
9.960.906
2018-05-03 2018-05-02 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
A - Award 874 874
2018-05-03 2018-05-03 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 882 2.747 47,29
2018-05-03 2018-05-03 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
D - Sale to Issuer -882 0 -100,00
2018-02-02 2017-12-31 5 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 25 1.865 1,36
2017-05-05 2017-05-03 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
A - Award 882 882
2017-05-03 2017-05-02 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 938 1.840 103,99
2017-05-03 2017-05-02 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
D - Sale to Issuer -938 0 -100,00
2017-02-07 2016-12-31 5 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 3 583 0,52
2017-02-03 2017-02-01 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 319 899 55,00
2017-02-03 2017-02-01 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
D - Sale to Issuer -319 0 -100,00
2016-12-06 2016-02-01 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 160 160 118,46 18.954 18.954
2016-11-03 2016-11-01 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Stock Equivalent Unit
A - Award 420 420 133,84 56.213 56.213
2016-05-03 2016-05-02 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
A - Award 938 938
2016-02-02 2016-02-01 4 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Restricted Stock Units
A - Award 319 319
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)